How this mutation affects STRADα function and its ability to interact with LKB1 is unknown, although histological staining of neuronal tissues of PMSE patients has suggested elevated mTOR pathway activity, which could potentially result from loss of LKB1 kinase activity. The gene discussed is STK11; the disease is polyhydramnios, megalencephaly, and symptomatic epilepsy.